Regeneron Pharmaceuticals Aktie
WKN: 881535 / ISIN: US75886F1075
|
22.04.2025 13:38:18
|
Regeneron Pharma Partners With FujiFilm Diosynth To Boost Capacity At $3 Bln Investment
(RTTNews) - Regeneron Pharma, Inc. (REGN), a biotechnology company, on Tuesday announced a major expansion of its manufacturing capacity through a new agreement with FujiFilm Diosynth Biotechnologies. The total investment is expected to be over $3 billion.
The technology transfer will begin immediately, and the agreement will last for ten years.
This new investment highlights Regeneron's commitment to providing innovative medicines.
As per the deal, Fujifilm will manufacture and supply bulk drug products for Regeneron's commercial biologic medicines at its facility in Holly Springs, North Carolina.
The company is also making major investments in New York, including an approximate $3.6 billion expansion of its Tarrytown campus. This project is expected to create 1,000 full-time, high-skill jobs and expand its research, preclinical manufacturing, and support facilities.
Regeneron said it will be building a new fill/finish manufacturing facility in Rensselaer, New York.
Additionally, the company has acquired a property of over 1 million square feet in Saratoga Springs, New York, to support production and potentially add more manufacturing capacity in the future.
In the pre-market trading, Regeneron Pharma is 0.15% higher at $562.34 on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Regeneron Pharmaceuticals Inc.mehr Nachrichten
|
17.11.25 |
Schwacher Handel: NASDAQ 100 zeigt sich zum Ende des Montagshandels leichter (finanzen.at) | |
|
17.11.25 |
Verluste in New York: NASDAQ 100 am Nachmittag in der Verlustzone (finanzen.at) | |
|
13.11.25 |
NASDAQ 100 aktuell: NASDAQ 100 verliert zum Handelsende (finanzen.at) | |
|
13.11.25 |
Börse New York in Rot: NASDAQ 100 nachmittags im Minus (finanzen.at) | |
|
13.11.25 |
Börse New York: S&P 500 liegt nachmittags im Minus (finanzen.at) | |
|
13.11.25 |
Angespannte Stimmung in New York: NASDAQ 100 sackt mittags ab (finanzen.at) | |
|
12.11.25 |
NASDAQ Composite Index-Papier Regeneron Pharmaceuticals-Aktie: So viel Verlust hätte eine Regeneron Pharmaceuticals-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
|
11.11.25 |
Börse New York: NASDAQ 100 zum Ende des Dienstagshandels mit Abgaben (finanzen.at) |